118 related articles for article (PubMed ID: 26967450)
1. The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
Li X; Zhu H; Zhang Y; Zhao W; Mi J; Hu J; Li J
Acta Haematol; 2016; 135(4):217-23. PubMed ID: 26967450
[TBL] [Abstract][Full Text] [Related]
2. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia.
Yu C; Kong QL; Zhang YX; Weng XQ; Wu J; Sheng Y; Jiang CL; Zhu YM; Cao Q; Xiong SM; Li JM; Xi XD; Chen SJ; Chen B
J Hematol Oncol; 2015 May; 8():48. PubMed ID: 25957890
[TBL] [Abstract][Full Text] [Related]
4. The percentage of peripheral blood blasts on day 7 of induction chemotherapy predicts response to therapy and survival in patients with acute myeloid leukemia.
Gao S; Tan Y; Liu X; Su L; Yu P; Han W; Cui J; Li W
Chin Med J (Engl); 2014; 127(2):290-3. PubMed ID: 24438618
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the peripheral blood cell counts changes during induction chemotherapy in Chinese patients with adult acute myeloid leukemia.
Huang YM; Wang YN; Zheng Y; Pan LL; Li Y; Li JG; Wang SY
Medicine (Baltimore); 2021 Feb; 100(8):e24614. PubMed ID: 33663070
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.
Covut F; Gupta D; Pinto R; Dambrosio N; El Jurdi N; Meyerson H; Ueda M; Kolk M; Creger R; Metheny L; Cooper BW; Caimi PF; Malek E; Otegbeye F; Lazarus HM; De Lima M; Tomlinson BK
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):73-82. PubMed ID: 30528848
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
Short NJ; Benton CB; Chen HC; Qiu P; Gu L; Pierce S; Brandt M; Maiti A; Min TL; Naqvi K; Quintas-Cardama A; Konopleva M; Kadia T; Cortes J; Garcia-Manero G; Ravandi F; Jabbour E; Kantarjian H; Andreeff M
Am J Hematol; 2016 Dec; 91(12):1221-1226. PubMed ID: 27474808
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
Holtzman NG; El Chaer F; Baer MR; Ali O; Patel A; Duong VH; Sausville EA; Singh ZN; Koka R; Zou YS; Etemadi A; Emadi A
Br J Haematol; 2020 Mar; 188(6):881-887. PubMed ID: 31804722
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemia.
Nakano H; Fujiwara SI; Ito S; Mashima K; Umino K; Minakata D; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Muroi K; Kanda Y
Hematol Oncol; 2017 Sep; 35(3):357-364. PubMed ID: 26639319
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between Effect of Induction Chemotherapy and Prognosis in AML Patients].
Wang BR; Zhang HB; Yu QN; Wu RN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1417-1423. PubMed ID: 34627419
[TBL] [Abstract][Full Text] [Related]
11. Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.
Elliott MA; Litzow MR; Letendre LL; Wolf RC; Hanson CA; Tefferi A; Tallman MS
Blood; 2007 Dec; 110(13):4172-4. PubMed ID: 17909077
[TBL] [Abstract][Full Text] [Related]
12. A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia.
Song J; Shang B; Pei Y; Shi M; Niu X; Dou L; Drokow EK; Xu F; Bai Y; Sun K
Leuk Res; 2021 Oct; 109():106638. PubMed ID: 34116372
[TBL] [Abstract][Full Text] [Related]
13. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
Ciftciler R; Demiroglu H; Haznedaroglu IC; Sayınalp N; Aksu S; Ozcebe O; Goker H; Aydın MS; Buyukasık Y
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):729-734. PubMed ID: 31540855
[TBL] [Abstract][Full Text] [Related]
14. Azacitidine for the treatment of relapsed and refractory AML in older patients.
Itzykson R; Thépot S; Berthon C; Delaunay J; Bouscary D; Cluzeau T; Turlure P; Prébet T; Dartigeas C; Marolleau JP; Recher C; Plantier I; Stamatoullas A; Devidas A; Taksin AL; Guièze R; Caillot D; Vey N; Adès L; Ifrah N; Dombret H; Fenaux P; Gardin C
Leuk Res; 2015 Feb; 39(2):124-30. PubMed ID: 25524177
[TBL] [Abstract][Full Text] [Related]
15. Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study.
Lacombe F; Arnoulet C; Maynadié M; Lippert E; Luquet I; Pigneux A; Vey N; Casasnovas O; Witz F; Béné MC
Leukemia; 2009 Feb; 23(2):350-7. PubMed ID: 18987664
[TBL] [Abstract][Full Text] [Related]
16. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
[TBL] [Abstract][Full Text] [Related]
17. Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
Campuzano-Zuluaga G; Deutsch Y; Salzberg M; Gomez A; Vargas F; Elias R; Kwon D; Goodman M; Ikpatt OF; Chapman JR; Watts J; Vega F; Swords R
Am J Hematol; 2016 Mar; 91(3):277-82. PubMed ID: 26663264
[TBL] [Abstract][Full Text] [Related]
18. [Results of acute myeloid leukemia treatment. Analysis of 63 patients between 2010-2014].
Fuentes M; Rojas P; Ernst D; Ocqueteau M; Bertin P; Sarmiento M; Ramírez P
Rev Med Chil; 2015 Oct; 143(10):1269-76. PubMed ID: 26633270
[TBL] [Abstract][Full Text] [Related]
19. [A new prognostic stratification for patients with acute myeloid leukemia].
Jiang B; Mi YC; Lin D; Cai XJ; Fu MW; Li W; Wang Y; Liu XP; Xue YP; Bian SG; Wang JX
Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):316-20. PubMed ID: 19576124
[TBL] [Abstract][Full Text] [Related]
20. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]